Jean-Claude Lubanda

Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population

Robert Dobrovolný, Lenka Dvořáková, J. Ledvinová et al. · Journal of Molecular Medicine · 2005 · 170 citations

Life Sciences, Genetics, Molecular Genetics +9

Natural history of the respiratory involvement in Anderson–Fabry disease

Sudheera Magage, Jean-Claude Lubanda, Z Susa et al. · Journal of Inherited Metabolic Disease · 2007 · 64 citations

Medicine, Internal Medicine, Pathology +11

Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease

Jean-Claude Lubanda, Ene Anijalg, Vladimı́r Bzdúch et al. · Genetics in Medicine · 2009 · 61 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +9

Percutaneous Mechanical Thrombectomy Using Rotarex® S Device in Acute Limb Ischemia in Infrainguinal Occlusions

Samuel Heller, Jean-Claude Lubanda, P Vařejka et al. · BioMed Research International · 2017 · 54 citations · Full text

Medicine, Orthopedic Surgery, Surgery +14

Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative

Derralynn Hughes, Patrício Aguiar, Patrick Deegan et al. · BMJ Open · 2020 · 38 citations · Full text

Medicine, Nephrology, Neurology +13